Product Information

KLOR-CON 8 MEQ TABLET is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $0.1181 per EA under NDC 00245531501. Its NADAC has been published 138 times since Jul 10, 2019.

FDA first approved this application on Apr 17, 1986. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

KLOR-CON 8 MEQ TABLET

potassium chloride
$0.1181per EA

Strength

600 mg/1

NDC

00245531501

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA019123

FDA Approved

4/17/1986

TE Code

AB2

On Market Since

4/17/1986

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for KLOR-CON 8 MEQ TABLET has been published 138 times since Jul 10, 2019, and over the history we have for it it has declined 71.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1181 per EA
All-time high$0.4102 (Oct 16, 2019)
All-time low$0.1181 (Aug 19, 2026)
52-week high$0.2078
52-week low$0.1181
Median price$0.2185
Average price$0.2330
Largest weekly change-40.7% (Feb 18, 2026)
Weeks tracked138
Tracking sinceJul 10, 2019

Price History

1W

-4.2%

1M

-4.2%

3M

-4.2%

6M

-4.2%

1Y

-43.2%

3Y

-71.2%

5Y

-71.2%

All

-71.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of KLOR-CON 8 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for KLOR-CON 8 MEQ TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1181 per EA (NDC 00245531501), effective Aug 19, 2026.

How has the price of KLOR-CON 8 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for KLOR-CON 8 MEQ TABLET has declined 71.2%. It has been tracked across 138 weekly CMS publications since Jul 10, 2019.

What are the highest and lowest recorded NADAC prices for KLOR-CON 8 MEQ TABLET?

Since Jul 10, 2019, the NADAC for KLOR-CON 8 MEQ TABLET has ranged from a low of $0.1181 (Aug 19, 2026) to a high of $0.4102 (Oct 16, 2019), with a median of $0.2185 per EA.

Are there cheaper alternatives to KLOR-CON 8 MEQ TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 8 MEQ TABLET, is $0.1020 per EA — about 14% below KLOR-CON 8 MEQ TABLET.

Who manufactures KLOR-CON 8 MEQ TABLET?

KLOR-CON 8 MEQ TABLET (NDC 00245531501) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.